ID

13279

Descripción

Effect of Indomethacin on the Progression of Alzheimer's Disease; ODM derived from: https://clinicaltrials.gov/show/NCT00432081

Link

https://clinicaltrials.gov/show/NCT00432081

Palabras clave

Versiones (1)
  1. 29/1/16 29/1/16 -
Subido en

29 de enero de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Alzheimer Disease NCT00432081

Inglés

Eligibility Alzheimer Disease NCT00432081

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
the patient will satisfy the dsm-iv criteria for dementia of the alzheimer’s type.
Descripción

dsm-iv criteria

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0220952
UMLS CUI [1,2]
C1387192
the patient will satisfy the nincds/adrda criteria for the clinical diagnosis of probable alzheimer’s disease (appendix i).
Descripción

nincds/adrda criteria

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2828081
the severity of dementia for each patient will be quantified by a mini-mental state examination (mmse) score between 10 and 26 (both inclusive).
Descripción

severity of dementia

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0451306
the patient is living at home or in a home for the elderly.
Descripción

residence

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0237096
the patient has a responsible caregiver who is able to provide information about the patient’s functional status.
Descripción

Caregiver

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0085537
written informed consent is obtained from the patient or the legally accepted representative.
Descripción

Informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
the patient satisfies the ninds-airen criteria for probable vascular dementia.
Descripción

Vascular dementia

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0011269
a known exaggerated pharmacological sensitivity or allergy to nsaid’s.
Descripción

Allergy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0003211
history of peptic ulceration, gastric surgery or gastrointestinal bleeding.
Descripción

Gastrointestinal status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0030920
UMLS CUI [2]
C0192398
UMLS CUI [3]
C0017181
current diagnosis of active peptic ulceration.
Descripción

peptic ulceration

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0030920
current diagnosis of severe and unstable cardiovascular disease.
Descripción

cardiovascular status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0007222
current diagnosis of renal failure.
Descripción

renal function

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0035078
advanced, severe and unstable disease of any type, other than alzheimer’s disease, that may interfere with primary and secondary variable evaluations, including a medical condition which should be expected to progress, recur, or change to such an extent that it may bias the assessment of the clinical or mental status of the patient to a significant degree or put the patient at special risk.
Descripción

Comorbidity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488
intake of any of the following concomitant medications: salicylates, coumarin derivatives, ace-inhibitors, loop diuretics.
Descripción

Pharmacotherapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0036075
UMLS CUI [2]
C0010207
UMLS CUI [3]
C0003015
UMLS CUI [4]
C0354100
intake of any of the following concomitant medications more than two months immediately prior or during the study: nsaid’s, systemic corticosteroids.
Descripción

Pharmacotherapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0003211
UMLS CUI [2]
C3653708
intake of any of the following concomitant medications with a possible effect on cognition: estrogen, deprenyl, vitamin e, neuroleptics, anticholinergics. patients using stable doses of cholinesterase inhibitors were eligible, with the provision that the dose should not be changed during the study. cholinesterase inhibitors could not be initiated during the study.
Descripción

Pharmacotherapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3541386
UMLS CUI [2]
C0086130
UMLS CUI [3]
C1142098
UMLS CUI [4]
C0040615
UMLS CUI [5]
C0242896
UMLS CUI [6,1]
C0008429
UMLS CUI [6,2]
C0008429
excessive use of alcohol (more than 5 units per day)
Descripción

Alcohol consumption

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001948
the patient is, either alone or with the aid of a caregiver, not able to reliably take the medication.
Descripción

Compliance

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0013216
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C1321605
Volver a la parte superior de la página

Similar models

Eligibility Alzheimer Disease NCT00432081

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
dsm-iv criteria
Item
the patient will satisfy the dsm-iv criteria for dementia of the alzheimer’s type.
boolean
C0220952 (UMLS CUI [1,1])
C1387192 (UMLS CUI [1,2])
nincds/adrda criteria
Item
the patient will satisfy the nincds/adrda criteria for the clinical diagnosis of probable alzheimer’s disease (appendix i).
boolean
C2828081 (UMLS CUI [1])
severity of dementia
Item
the severity of dementia for each patient will be quantified by a mini-mental state examination (mmse) score between 10 and 26 (both inclusive).
boolean
C0451306 (UMLS CUI [1])
residence
Item
the patient is living at home or in a home for the elderly.
boolean
C0237096 (UMLS CUI [1])
Caregiver
Item
the patient has a responsible caregiver who is able to provide information about the patient’s functional status.
boolean
C0085537 (UMLS CUI [1])
Informed consent
Item
written informed consent is obtained from the patient or the legally accepted representative.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Vascular dementia
Item
the patient satisfies the ninds-airen criteria for probable vascular dementia.
boolean
C0011269 (UMLS CUI [1])
Allergy
Item
a known exaggerated pharmacological sensitivity or allergy to nsaid’s.
boolean
C0020517 (UMLS CUI [1,1])
C0003211 (UMLS CUI [1,2])
Gastrointestinal status
Item
history of peptic ulceration, gastric surgery or gastrointestinal bleeding.
boolean
C0030920 (UMLS CUI [1])
C0192398 (UMLS CUI [2])
C0017181 (UMLS CUI [3])
peptic ulceration
Item
current diagnosis of active peptic ulceration.
boolean
C0030920 (UMLS CUI [1])
cardiovascular status
Item
current diagnosis of severe and unstable cardiovascular disease.
boolean
C0007222 (UMLS CUI [1])
renal function
Item
current diagnosis of renal failure.
boolean
C0035078 (UMLS CUI [1])
Comorbidity
Item
advanced, severe and unstable disease of any type, other than alzheimer’s disease, that may interfere with primary and secondary variable evaluations, including a medical condition which should be expected to progress, recur, or change to such an extent that it may bias the assessment of the clinical or mental status of the patient to a significant degree or put the patient at special risk.
boolean
C2348568 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
Pharmacotherapy
Item
intake of any of the following concomitant medications: salicylates, coumarin derivatives, ace-inhibitors, loop diuretics.
boolean
C0036075 (UMLS CUI [1])
C0010207 (UMLS CUI [2])
C0003015 (UMLS CUI [3])
C0354100 (UMLS CUI [4])
Pharmacotherapy
Item
intake of any of the following concomitant medications more than two months immediately prior or during the study: nsaid’s, systemic corticosteroids.
boolean
C0003211 (UMLS CUI [1])
C3653708 (UMLS CUI [2])
Pharmacotherapy
Item
intake of any of the following concomitant medications with a possible effect on cognition: estrogen, deprenyl, vitamin e, neuroleptics, anticholinergics. patients using stable doses of cholinesterase inhibitors were eligible, with the provision that the dose should not be changed during the study. cholinesterase inhibitors could not be initiated during the study.
boolean
C3541386 (UMLS CUI [1])
C0086130 (UMLS CUI [2])
C1142098 (UMLS CUI [3])
C0040615 (UMLS CUI [4])
C0242896 (UMLS CUI [5])
C0008429 (UMLS CUI [6,1])
C0008429 (UMLS CUI [6,2])
Alcohol consumption
Item
excessive use of alcohol (more than 5 units per day)
boolean
C0001948 (UMLS CUI [1])
Compliance
Item
the patient is, either alone or with the aid of a caregiver, not able to reliably take the medication.
boolean
C0013216 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C1321605 (UMLS CUI [1,3])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial